Elagolix, a novel, orally bioavailable GnRH antagonist under investigation for the treatment of endometriosis-related pain

Mohammad Ezzati, Bruce R. Carr

Research output: Contribution to journalReview articlepeer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Elagolix, a novel, orally bioavailable GnRH antagonist under investigation for the treatment of endometriosis-related pain'. Together they form a unique fingerprint.

Medicine & Life Sciences